This capability allows the company to shorten lead times and reduce minimums, making these packaging options more feasible for small and mid-size brands.
A state-of-the-art digital press now enables Overnight Labels (Deer Park, NY), an award-winning manufacturer of custom labels, shrink sleeves, and flexible packaging, to lower order minimums for its clients for flexible packaging such as standup pouches, single-use sample packets, stick packs, and bags. This capability allows the company to shorten lead times and reduce minimums, making these packaging options more feasible for small and mid-size brands. Overnight Labels will be an exhibitor at the upcoming Natural Products Expo West trade show in Anaheim, CA, in March, at Booth #3678.
The company says it is now one of the only full-service packaging converters in the U.S. with a HP Indigo 25K press. Don Earl, Overnight Labels’ president, described its benefits in a press release: “Quantities for flexible packaging are typically 5,000 for roll stock and 10,000 for bags and pouches. Because of the quicker turnaround production time, no plate charges or setup fees, and higher quality results, we are able to lower our minimums and level the playing field for emerging players in multiple categories, including beauty, food, nutritional supplements, and cannabis.”
He added: “This high-tech press was designed to work with our new lamination and pouch-making equipment and allows us to help most companies achieve their vision. We can help lower inventory, create limited edition or personalized units, and most importantly produce beautiful packaging that stands up and stands out on shelves and online.”
The company’s pouch orders and roll stick minimums start at 2500 per SKU, with turnaround times “flexible and typically faster than industry averages for flexible packaging.” Its products include traditional, recyclable, and compostable options for flexible packaging, labels, and shrink sleeves.
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.